DAIHAN Scientific Co. Ltd (131220) — Cash Flow-to-Debt Ratio
DAIHAN Scientific Co. Ltd (131220) has a Cash Flow-to-Debt Ratio of 0.03x as of September 2025, meaning its operating cash flow of ₩361.12 Million could theoretically repay 0% of its total liabilities (₩13.84 Billion) in one year. Explore DAIHAN Scientific Co. Ltd strategic investment ratio to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
DAIHAN Scientific Co. Ltd Cash Flow-to-Debt Ratio (2012–2024)
Historical debt coverage capacity for DAIHAN Scientific Co. Ltd across 12 annual periods. Also explore DAIHAN Scientific Co. Ltd assets under control for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for DAIHAN Scientific Co. Ltd (2012–2024)
Year-by-year debt coverage analysis for DAIHAN Scientific Co. Ltd. For market capitalisation and broader financial context, see DAIHAN Scientific Co. Ltd stock valuation.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.16x | ₩3.99 Billion | ₩25.59 Billion | ▼ -19.4% |
| 2023 | 0.19x | ₩4.79 Billion | ₩24.80 Billion | ▼ -1.4% |
| 2022 | 0.20x | ₩4.51 Billion | ₩23.02 Billion | ▲ +5.8% |
| 2021 | 0.19x | ₩4.13 Billion | ₩22.29 Billion | ▼ -45.4% |
| 2020 | 0.34x | ₩5.35 Billion | ₩15.74 Billion | ▲ +125.6% |
| 2019 | 0.15x | ₩2.44 Billion | ₩16.20 Billion | ▼ -46.4% |
| 2018 | 0.28x | ₩3.76 Billion | ₩13.39 Billion | ▼ -21.0% |
| 2017 | 0.36x | ₩4.58 Billion | ₩12.89 Billion | ▲ +50.4% |
| 2016 | 0.24x | ₩4.12 Billion | ₩17.45 Billion | ▲ +361.2% |
| 2015 | 0.05x | ₩898.12 Million | ₩17.53 Billion | ▼ -63.1% |
| 2014 | 0.14x | ₩2.59 Billion | ₩18.66 Billion | ▲ +260.3% |
| 2012 | 0.04x | ₩565.94 Million | ₩14.69 Billion | — |